Crossmark

miR-190 enhances endocrine therapy sensitivity by regulating SOX9 expression in breast cancer

Crossref DOI link: https://doi.org/10.1186/s13046-019-1039-9

Published Online: 2019-01-18

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yu, Yue

Yin, Wen

Yu, Zhi-Hao

Zhou, Yan-Jun

Chi, Jiang-Rui

Ge, Jie

Cao, Xu-Chen https://orcid.org/0000-0003-3216-6673
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81502518)

National Natural Science Foundation of China (81372843)

National Natural Science Foundation of China (81702624)

Natural Science Foundation of Tianjin City (17JCQNJC10400)
License Information

Text and Data Mining valid from 2019-01-18
More Information

Article History

Received: 28 October 2018

Accepted: 13 January 2019

First Online: 18 January 2019

Ethics approval and consent to participate

: This study was approved by the Institutional Review Board of TMUCIH and written consent was obtained from all participants.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.